Sight Sciences (NASDAQ:SGHT – Get Free Report) had its target price dropped by analysts at Stifel Nicolaus from $6.00 to $5.00 in a research report issued to clients and investors on Thursday,Benzinga ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...

Iantrek has reached an exciting milestone as we transition from development of our bio-interventional technologies to ...

We present a case of unilateral, secondary open-angle glaucoma due to an underlying diffuse iris melanoma. The patient was referred by his ophthalmologist with uncontrolled, elevated intraocular ...

Ophthalmologists must know how to identify and manage pseudoexfoliation glaucoma, one of the most damaging forms of the disease, according to a speaker at Hawaiian Eye 2025.

It is implanted through the trabecular meshwork and back wall of Schlemm's canal, directly into scleral tissue. 1 In a new 36-month follow-up analysis of the company’s 2 Phase 3 pivotal clinical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Failure of the Paul Glaucoma Implant occurred in 8% ...

Ryals. ““Additionally, by changing the injection routes, different tissues become accessible.” The team is using intravitreal injections to reach ganglion cells and intracameral delivery to access the ...

Made from medical-grade titanium, iDose TR is implanted through the trabecular meshwork and back wall of Schlemm's canal, directly into scleral tissue. Once implanted, 75 mcg of a novel ...

Made from medical-grade titanium, iDose TR is implanted through the trabecular meshwork and back wall of Schlemm’s canal, directly into scleral tissue. Once implanted, 75 mcg of a novel, ...

Professor at the University of Nebraska Medical Center shared “All conventional approaches have focused on the trabecular meshwork and the inner canal wall. We have shown empirically and ...